Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function

Completed · Phase 2

Conditions studied: Stroke, Muscle Spasticity, Motor Neuron Disease

In brief

The purpose of this study is to evaluate the safety of injections of botulinum toxin Type A in patients with reduced lung function and focal upper limb poststroke spasticity

Key facts

Study ID

NCT00076687

Run by

Allergan

People needed

155

Starts

2003-10-01

Expected to finish

2009-08-01

Last updated by the study team

2011-10-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Abnormal pulmonary function test results;
• focal, upper limb spasticity, upper motor neuron syndrome

You may not qualify if…

• Previous exposure to botulinum toxin of any serotype

Where it is running

• Study site — Miami, Florida, United States
• Study site — Prague, Czechia
• Study site — Szeged, Hungary
• Study site — Warsaw, Poland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.